These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25487143)

  • 21. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement.
    Caminschi I; Proietto AI; Ahmet F; Kitsoulis S; Shin Teh J; Lo JC; Rizzitelli A; Wu L; Vremec D; van Dommelen SL; Campbell IK; Maraskovsky E; Braley H; Davey GM; Mottram P; van de Velde N; Jensen K; Lew AM; Wright MD; Heath WR; Shortman K; Lahoud MH
    Blood; 2008 Oct; 112(8):3264-73. PubMed ID: 18669894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.
    Khalil SM; Tonkin DR; Snead AT; Parks GD; Johnston RE; White LJ
    J Virol; 2014 Aug; 88(16):9182-96. PubMed ID: 24899195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice.
    Stylianou E; Pepponi I; van Dolleweerd CJ; Paul MJ; Ma JK; Reljic R
    Vaccine; 2011 Mar; 29(12):2279-86. PubMed ID: 21272603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
    Grossmann C; Tenbusch M; Nchinda G; Temchura V; Nabi G; Stone GW; Kornbluth RS; Uberla K
    BMC Immunol; 2009 Aug; 10():43. PubMed ID: 19650904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting Antigens to Different Receptors on Conventional Type 1 Dendritic Cells Impacts the Immune Response.
    Fossum E; Tesfaye DY; Bobic S; Gudjonsson A; Braathen R; Lahoud MH; Caminschi I; Bogen B
    J Immunol; 2020 Aug; 205(3):661-673. PubMed ID: 32591401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy.
    Yan Z; Wu Y; Du J; Li G; Wang S; Cao W; Zhou X; Wu C; Zhang D; Jing X; Li Y; Wang H; Gao Y; Qi Y
    Oncotarget; 2016 Jun; 7(26):40437-40450. PubMed ID: 27250027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination.
    Antonio-Herrera L; Badillo-Godinez O; Medina-Contreras O; Tepale-Segura A; García-Lozano A; Gutierrez-Xicotencatl L; Soldevila G; Esquivel-Guadarrama FR; Idoyaga J; Bonifaz LC
    Front Immunol; 2018; 9():2212. PubMed ID: 30319653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen Delivery to DEC205
    Silva MO; Almeida BS; Sales NS; Diniz MO; Aps LRMM; Rodrigues KB; Silva JR; Moreno ACR; Porchia BFMM; Sulczewski FB; Boscardin SB; Ferreira LCS
    Int J Biol Sci; 2021; 17(11):2944-2956. PubMed ID: 34345218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-12p40/IL-10 Producing preCD8α/Clec9A+ Dendritic Cells Are Induced in Neonates upon Listeria monocytogenes Infection.
    Torres D; Köhler A; Delbauve S; Caminschi I; Lahoud MH; Shortman K; Flamand V
    PLoS Pathog; 2016 Apr; 12(4):e1005561. PubMed ID: 27074026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells.
    Chen BY; Zhou G; Li QL; Lu JS; Shi DY; Pang XB; Zhou XW; Yu YZ; Huang PT
    Immunol Lett; 2017 Oct; 190():118-124. PubMed ID: 28802641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo.
    Volckmar J; Knop L; Hirsch T; Frentzel S; Erck C; van Ham M; Stegemann-Koniszewski S; Bruder D
    J Vis Exp; 2021 Feb; (168):. PubMed ID: 33616089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo targeting of human DC-SIGN drastically enhances CD8⁺ T-cell-mediated protective immunity.
    Hesse C; Ginter W; Förg T; Mayer CT; Baru AM; Arnold-Schrauf C; Unger WW; Kalay H; van Kooyk Y; Berod L; Sparwasser T
    Eur J Immunol; 2013 Oct; 43(10):2543-53. PubMed ID: 23784881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice.
    Cao J; Jin Y; Li W; Zhang B; He Y; Liu H; Xia N; Wei H; Yan J
    BMC Immunol; 2013 Aug; 14():39. PubMed ID: 23941509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity.
    Kreutz M; Giquel B; Hu Q; Abuknesha R; Uematsu S; Akira S; Nestle FO; Diebold SS
    PLoS One; 2012; 7(7):e40208. PubMed ID: 22808118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin.
    Sancho D; Mourão-Sá D; Joffre OP; Schulz O; Rogers NC; Pennington DJ; Carlyle JR; Reis e Sousa C
    J Clin Invest; 2008 Jun; 118(6):2098-110. PubMed ID: 18497879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
    Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
    Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of B cell responses to Clec9A-targeted antigen.
    Park HY; Light A; Lahoud MH; Caminschi I; Tarlinton DM; Shortman K
    J Immunol; 2013 Nov; 191(10):4919-25. PubMed ID: 24123689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A purified acidic polysaccharide from Sarcandra glabra as vaccine adjuvant to enhance anti-tumor effect of cancer vaccine.
    Liu W; Gong X; Luo J; Jiang L; Lu W; Pan C; Yao W; Gao X; Tian H
    Carbohydr Polym; 2021 Jul; 263():117967. PubMed ID: 33858570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas.
    Picco G; Beatson R; Taylor-Papadimitriou J; Burchell JM
    Eur J Immunol; 2014 Jul; 44(7):1947-55. PubMed ID: 24648154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.
    Poulin LF; Salio M; Griessinger E; Anjos-Afonso F; Craciun L; Chen JL; Keller AM; Joffre O; Zelenay S; Nye E; Le Moine A; Faure F; Donckier V; Sancho D; Cerundolo V; Bonnet D; Reis e Sousa C
    J Exp Med; 2010 Jun; 207(6):1261-71. PubMed ID: 20479117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.